Results 41 to 50 of about 1,224,792 (212)
Nature and Science of Sleep, 2023 Asim Roy,1 Diane Ito,2 Susan Morris,3 Shawn Candler,4 Judi Profant,3 Charles Bae5 1Ohio Sleep Medicine Institute, Dublin, OH, USA; 2Stratevi LLC, Santa Monica, CA, USA; 3Jazz Pharmaceuticals, Palo Alto, CA, USA; 4Jazz Pharmaceuticals, Philadelphia, PA ...
Roy A +5 more
doaj
Nature and Science of Sleep, 2022 Yves Dauvilliers,1,2 Richard K Bogan,3 Karel Šonka,4 Markku Partinen,5 Nancy Foldvary-Schaefer,6 Michael J Thorpy7 1Sleep and Wake Disorders Centre, Department of Neurology, Gui de Chauliac Hospital, Montpellier, France; 2University of Montpellier ...
Dauvilliers Y +5 more
doaj
Novel Psychoactive Substances 14Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs [PDF]
, 2017 A feature of human culture is that we can learn to consume chemical compounds, derived from natural plants or synthetic fabrication, for their psychoactive effects.
Boris B. , Quednow +8 more
core +1 more source
Long-Term Effect of Sodium Oxybate (Xyrem®) in Spasmodic Dysphonia with Vocal Tremor
Tremor and Other Hyperkinetic Movements, 2013 Background: Symptoms of spasmodic dysphonia (SD) are usually managed successfully with botulinum toxin injections. Vocal tremor (VT), which accompanies SD, has a poor response to this treatment.Case Report: We report a case of a female with SD and VT who
Kristina Simonyan, Steven J. Frucht
doaj +1 more source
Long-Term Daytime Use of Sodium Oxybate in Laryngeal Dystonia: A Follow-Up Online Survey Study. [PDF]
LaryngoscopeO'Flynn LC, Simonyan K.
europepmc +2 more sources
Medical treatment of dystonia [PDF]
, 2016 Therapeutic strategies in dystonia have evolved considerably in the past few decades. Three major treatment modalities include oral medications, botulinum toxin injections and surgical therapies, particularly deep brain stimulation.
Pichet Termsarasab +2 more
core +2 more sources
Reduced insular γ‐aminobutyric acid in fibromyalgia [PDF]
, 2012 Objective Recent scientific findings have reinvigorated interest in examining the role of γ‐aminobutyric acid (GABA), the major inhibitory central nervous system neurotransmitter, in chronic pain conditions.
Borsook +15 more
core +1 more source
Narcolepsy and Cataplexy – a practical approach to diagnosis and managing the impact of this chronic condition on children and their families [PDF]
, 2017 Narcolepsy is a relatively common neurological condition affecting the regulation of normal sleep/wake cycles leading to excessive daytime sleepiness (EDS).
Blackwell, J +3 more
core +1 more source
Successful Treatment of Narcolepsy and Cataplexy: A Review
Canadian Respiratory Journal, 2005 A 25-year-old woman with narcolepsy and cataplexy was treated with well-recognized drugs for these conditions. Because she did not respond, a decision was made to treat her with sodium oxybate.
B Lockrane, P Bhatia, Robin Gore
doaj +1 more source
Development of responder definitions for fibromyalgia clinical trials [PDF]
, 2012 Objective To develop responder definitions for fibromyalgia (FM) clinical trials using key symptom and function domains. Methods Twenty‐four candidate responder definitions were developed by expert consensus and were evaluated in 12 randomized ...
Ang +38 more
core +1 more source